Skip to content

Effect of aniseed in menopausal symptoms in women

Effect of Anisoon in Menopausal Women with Psychological Symptoms: A Randomized Placebo-Controlled Study - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/02/039961
Enrollment
60
Registered
2022-02-02
Start date
Unknown
Completion date
Unknown
Last updated
2024-03-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: R398- Other symptoms and signs involvingthe genitourinary system

Interventions

Intervention1: Tukhme Anisoon: Four grams, in two divided doses twice daily, in capsule will be administered orally for 8 weeks Control Intervention1: Placebo: roasted rice flour. Dose and duration sa

Sponsors

National Institute of Unani Medicine
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Women aged 40 to 60 years. Women who either postmenopausal for =12 months or peri-menopausal (with amenorrhea lasting 2 to 11 months in the preceding year) will be included. Peri-menopausal women = 40 years old and had no other demonstrable reason for their amenorrhea.4 Women with psychological menopausal symptoms as per Depression Anxiety and Stress Scale(DASS-21 scale). Women with other menopausal symptoms such as vasomotor and somatic symptoms as per Modified Kupperman Index

Exclusion criteria

Exclusion criteria: Diagnosed cases of major depressive disorder, bipolar disorder, panic and phobic disorder, etc. Women with known systemic and endocrine diseases like uncontrolled hypertension and uncontrolled diabetes mellitus. Women with undiagnosed vaginal bleeding, history of endometrial hyperplasia, rapidly growing leiomyomata, history of surgical menopause. Women with hypersensitivity to drugs and past and present history of taking HRT, anxiolytics, antidepressants, mood stabilizers, and sedatives within two months. Pregnant and lactating women. Women with any kind of malignancies

Design outcomes

Primary

MeasureTime frame
Change in DASS-21 questionnaireTimepoint: Every month for 4 months

Secondary

MeasureTime frame
Change in Modified Kupperman Index questionnaire and change in Menopause Symptoms Treatment Satisfaction Questionnaire (MS-TSQ)Timepoint: Every month for 4 months

Countries

India

Contacts

Public ContactDr Arshiya Sultana

National Institute of Unani Medicine

arfasiddiqui770404@gmail.com8081880967

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026